21st Annual PEGS Boston Summit 2025
ÀÏÁ¤ : 2025³â 5¿ù 12-16ÀÏ
°³ÃÖ: Omni Boston Hotel at the Seaport, MA, USA
ÇØ´ç ÄÁÆÛ·±½º´Â Á¾·áµÇ¾ú½À´Ï´Ù.
Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_

Catalog Download
Catalog

´Ü¹éÁú¡¤Ç×ü °øÇÐ ¿¬±¸ÀÇ Çâ»ó

Engineering Stream

°øÇÐ ½ºÆ®¸²

  • Display of Biologics
    ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ µð½ºÇ÷¹ÀÌ

  • Engineering Antibodies
    Ç×ü °øÇÐ

  • Machine Learning for Protein Engineering
    ´Ü¹éÁú ¿£Áö´Ï¾î¸µ¿ë ±â°èÇнÀ

Oncology Stream

Á¾¾ç ½ºÆ®¸²

  • Antibodies for Cancer Therapy
    ¾ÏÄ¡·á¿ë Ç×ü

  • Emerging Targets for Oncology & Beyond
    Á¾¾ç ÀÌ¿Ü ½Å±Ô Ÿ±ê

  • Driving Clinical Success in Antibody-Drug Conjugates
    Ç×ü¾à¹°Á¢ÇÕü(ADC)ÀÇ ÀÓ»óÀû ¼º°øÀÇ ÃßÁø

Multispecifics Stream

´ÙÁ߯¯À̼º ½ºÆ®¸²

Immunotherapy Stream

¸é¿ªÄ¡·á ½ºÆ®¸²

  • Advances in Immunotherapy
    ¸é¿ªÄ¡·áÀÇ Áøº¸

  • Engineering Cell Therapies
    ¼¼Æ÷Ä¡·á °øÇÐ

  • Next-Generation Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á

Expression Stream

¹ßÇö ½ºÆ®¸²

  • Difficult-to-Express Proteins
    ¹ßÇöÀÌ ¾î·Á¿î ´Ü¹éÁú

  • Optimizing Protein Expression
    ´Ü¹éÁú ¹ßÇöÀÇ ÃÖÀûÈ­

  • Maximizing Protein Production Workflows
    ´Ü¹éÁú »ý»ê ¿öÅ©Ç÷οìÀÇ ÃÖ´ëÈ­

Analytical

ºÐ¼®¹ý ½ºÆ®¸²

  • ML and Digital Integration in Biotherapeutic Analytics
    ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¼®¿¡¼­ ML°ú µðÁöÅÐ ÅëÇÕ

  • Biophysical Methods
    »ý¹°¹°¸®ÇÐÀû ¹æ¹ý

  • Characterization for Novel Biotherapeutics
    ½Å±Ô ¹ÙÀÌ¿ÀÀǾàǰÀÇ Æ¯¼º Æò°¡

Terapeutics Stream

½Å±Ô Ä¡·á ½ºÆ®¸²

  • Biologics for Immunology Indications
    ÀûÀÀ ¸é¿ª¿ë ¹ÙÀÌ¿À·ÎÁ÷½º

  • Radiopharmaceutical Therapies
    ¹æ»ç¼º ÀǾàǰ Ä¡·á

  • Next-Generation Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á

Machine Learning Stream

±â°èÇнÀ ½ºÆ®¸²

  • ML and Digital Integration in Biotherapeutic Analytics
    ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¼®¿¡¼­ ML°ú µðÁöÅÐ ÅëÇÕ

  • Predicting Immunogenicity with AI/ML Tools
    AI/ML Åø¿¡ ÀÇÇÑ ¸é¿ª¿ø¼º ¿¹Ãø

  • Machine Learning for Protein Engineering
    ´Ü¹éÁú ¿£Áö´Ï¾î¸µ¿ë ±â°èÇнÀ

Short Courses

¼îÆ®ÄÚ½º

Àü¹®ÀûÀÎ ÅäÇÈÀ» ½ÉÃþÀûÀ¸·Î ´Ù·ç°í, Àü¹® °­»çÀÇ Áöµµ·Î ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

Training Seminars

Æ®·¹ÀÌ´× ¼¼¹Ì³ª

ÀÎÅÍ·¢Æ¼ºêÀÎ ÇнÀ ¹× ¶óÀ̺ê Áöµµ¿¡ ÀÇÇØ ÁýÁßÀûÀÎ ÅäÇÈ¿¡ ´ëÇØ ½Ç¿ëÀûÀÎ ½ºÅ³ ¹× Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ½À´Ï´Ù.

Watch Highlights From 2024

PEGS Boston SummitÀº ¹ÙÀÌ¿À·ÎÁ÷½º °³¹ß ÇÕ¸®È­¿¡ ÇʼöÀûÀÎ ¾÷°è ÄÁÆÛ·±½º

2025³â PEGS Boston SummitÀº Áö±Ý±îÁöÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼º°øÀ» ¹ÙÅÁÀ¸·Î ¹ÙÀÌ¿À·ÎÁ÷½º¡¤´Ü¹éÁú ¿£Áö´Ï¾î¸µÀÇ ÇÁ¸®¹Ì¾î À̺¥Æ®·Î¼­ÀÇ ÀüÅëÀ» À̾ °ÍÀÔ´Ï´Ù. ÀÌ ¼­¹Ô¿¡¼­´Â ÀÌ ºÐ¾ßÀÇ Àü¹®°¡, À̳뺣ÀÌÅÍ, ¸®´õ·Î ±¸¼ºµÈ ±Û·Î¹ú Ä¿¹Â´ÏƼ°¡ ÇÑÀÚ¸®¿¡ ¸ð¿© ÀǾàǰ °³¹ß, ´Ü¹éÁú¡¤Ç×ü °øÇÐ, ¸é¿ªÄ¡·á, ¹æ»ç¼± ¿ä¹ý, AI/ML µå¸®ºì ¹ÙÀÌ¿À·ÎÁ÷½º ¿¬±¸ÀÇ ÃֽŠÁøº¸¿¡ ´ëÇØ ÃÖ÷´Ü ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. 300°³ ÀÌ»óÀÇ ÇÁ·¹Á¨Å×À̼Ç, ºê·¹ÀÌÅ©¾Æ¿ô ¼¼¼Ç, ÀÎÅÍ·¢Æ¼ºê ¼¼¹Ì³ª¸¦ ÅëÇØ ³×Æ®¿öÅ©¸¦ ±¸ÃàÇϰí, ¹è¿ì°í, °¡Ä¡ ÀÖ´Â Çù¾÷¿¡ Âü°¡ÇÒ ¼ö ÀÖ´Â ÃÖ°íÀÇ ±âȸ°¡ Á¦°øµË´Ï´Ù. Àü½ÃȦ¿¡¼­´Â À̹ø¿¡µµ žŬ·¡½º Á¦Ç°¡¤¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡ ÀÇÇØ ¹ß°ß, Çõ½Å, Áñ°Å¿òÀ» À§ÇÑ ¸ðÀÓÀÇ Àå¼Ò°¡ ¸¶·ÃµË´Ï´Ù. ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ ¹Ì·¡¸¦ Çü¼ºÇÏ´Â ºê·¹ÀÌÅ©½º·çÀÇ ´ÙÀ½ ¹°°áÀÇ ÀϺÎÀÎ PEGS Boston Summit¿¡ ¸¹Àº °ü½É ºÎʵ右´Ï´Ù.

2400+ Participants
350+ Speakers
20 Tracks
120+ Exhibitors

PEGS Boston 2025 Ç÷¹³Ê¸® ±âÁ¶ ¿¬»ç

Puja Sapra, PhD

Puja Sapra, PhD
Senior Vice President, Biologics Engineering & Oncology Targeted Delivery, AstraZeneca Pharmaceuticals, Inc.

Ellen Puré, PhD

Ellen Puré, PhD
Chair & Professor, Biomedical Sciences, University of Pennsylvania

ÆÄÀ̾î»çÀ̵å ê : ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ´ÙÀ½ ±Ëµµ¿¡ Æí½Â
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿¡ ´ëÇÑ ÅõÀÚ¡¤Á¦ÈÞ¡¤M&AÀÇ µ¿Çâ

Jakob Dupont, MD

MODERATOR:
Jakob Dupont, MD
Executive Partner, Sofinnova Investments

Michal Preminger, PhD

PANELIST:
Michal Preminger, PhD, MBA
Regional Head, East North America, Johnson & Johnson Innovation LLC

Shyam Masrani

PANELIST:
Shyam Masrani
Principal, Medicxi

Uciane Scarlett, PhD

PANELIST:
Uciane Scarlett, PhD
Principal, MPM Capital

Anthony B. Barry, PhD

PANELIST:
Anthony B. Barry, PhD
Executive Director, ES&I Lead, Biotherapeutics, Technologies, and Digital, Pfizer Inc.

Testimonial
FairJourneyBiologics GenScript-CROIntegral-Molecular_NEW  OmniAb UnchainedLabs

PEGS Boston SummitÀÇ ½Å